Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies

Last 30 days: 66 accesses
Last 365 days: 1023 accesses
All time: 12633 accesses

Francisco J Esteva^*, Carol D Cheli, Herbert Fritsche, Monica Fornier, Dennis Slamon, Robert P Thiel, Diana Luftner and Farooq Ghani